These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 6300649)

  • 41. Activation of protein kinase C increases Ca2+ sensitivity of secretory response of GH3 pituitary cells.
    Haymes AA; Hinkle PM
    Am J Physiol; 1993 Apr; 264(4 Pt 1):C1020-8. PubMed ID: 7682770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of cyclic AMP accumulation in GH3 cells by a phorbol ester and thyroliberin.
    Quilliam LA; Dobson PR; Brown BL
    Biochem Biophys Res Commun; 1985 Jun; 129(3):898-903. PubMed ID: 2409970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of thyroxine and of thyrotropin releasing hormone on cyclic AMP concentration in the anterior pituitary gland in vitro.
    Pawlikowski M; Karasek E; Kunert-Radek J; Lewandowski J
    Endocrinol Exp; 1977 Mar; 11(1):33-6. PubMed ID: 192536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidermal growth factor stimulates the prolactin synthesis and secretion in rat pituitary cells in culture (GH4C1 cells) by increasing the intracellular concentration of free calcium.
    Aanestad M; Røtnes JS; Torjesen PA; Haug E; Sand O; Bjøro T
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):361-6. PubMed ID: 8388615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and adrenocorticotropin hormone release.
    Reisine T
    J Pharmacol Exp Ther; 1984 Apr; 229(1):14-20. PubMed ID: 6142943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mediation by calcium of thyrotropin--releasing hormone action on the prolactin promoter via transcription factor pit-1.
    Yan GZ; Bancroft C
    Mol Endocrinol; 1991 Oct; 5(10):1488-97. PubMed ID: 1775132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of prolactin synthesis and of adenosine 3':5'-cyclic phosphate formation by prostaglandins and thyroliberin in cultured rat pituitary cells.
    Gautvik KM; Kriz M
    Biochem J; 1976 Apr; 156(1):111-7. PubMed ID: 182137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tetracaine, propranolol and trifluoperazine inhibit thyrotropin releasing hormone-induced prolactin secretion from GH3 cells by displacing membrane calcium: further evidence that TRH acts to mobilize cellular calcium.
    Thaw C; Wittlin SD; Gershengorn MC
    Endocrinology; 1982 Dec; 111(6):2138-40. PubMed ID: 6814898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium-dependent effects of maitotoxin on phosphoinositide breakdown and on cyclic AMP accumulation in PC12 and NCB-20 cells.
    Gusovsky F; Yasumoto T; Daly JW
    Mol Pharmacol; 1989 Jul; 36(1):44-53. PubMed ID: 2546052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasoactive intestinal peptide increases intracellular free calcium in rat and human pituitary tumour cells in vitro.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS
    J Endocrinol; 1987 Jul; 114(1):119-23. PubMed ID: 3116135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of action of inhibitors of prolactin secretion in GH3 pituitary cells. II. Blockade of voltage-dependent Ca2+ channels.
    Wolfe SE; Brostrom MA
    Mol Pharmacol; 1986 Apr; 29(4):420-6. PubMed ID: 2422534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
    Martinez de la Escalera G; Weiner RI
    Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells.
    Kanasaki H; Fukunaga K; Takahashi K; Miyazaki K; Miyamoto E
    Biol Reprod; 1999 Jul; 61(1):319-25. PubMed ID: 10377065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the involvement of cyclic AMP and extracellular Ca2+ in the regulation of hormone release from rat pituitary tumour (GH3) cells in culture.
    Sletholt K; Haug E; Gautvik KM
    Biosci Rep; 1987 Feb; 7(2):93-105. PubMed ID: 2443198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of calmodulin antagonists on hormone release and cyclic AMP levels in GH3 pituitary cells.
    Sletholt K; Haug E; Gordeladze J; Sand O; Gautvik KM
    Acta Physiol Scand; 1987 Jun; 130(2):333-43. PubMed ID: 3037857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic stimulation of prolactin release by phorbol ester, A23187 and forskolin.
    Delbeke D; Kojima I; Dannies PS; Rasmussen H
    Biochem Biophys Res Commun; 1984 Sep; 123(2):735-41. PubMed ID: 6091639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum-induced sensitization of cyclic AMP accumulation in C62B rat glioma cells.
    Toews ML; Hoffman JM; Liewer SA; Arneson-Rotert LJ
    J Pharmacol Exp Ther; 1992 Aug; 262(2):471-8. PubMed ID: 1380077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of TGF-beta1 on prolactin synthesis and secretion: an in-vitro study.
    Coya R; Alvarez CV; Perez F; Gianzo C; Diéguez C
    J Neuroendocrinol; 1999 May; 11(5):351-60. PubMed ID: 10320562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium influx is not required for thyrotropin-releasing hormone stimulation of prolactin release from GH3 cells.
    Gershengorn MC; Thaw C; Gerry RH
    Cell Calcium; 1983 Apr; 4(2):117-24. PubMed ID: 6409414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potentiation of thyrotropin releasing hormone-induced inositol phospholipid metabolism and Ca2+ mobilization by cyclic AMP-increasing agents.
    Suzuki R; Takenawa T
    J Biochem; 1987 Sep; 102(3):447-50. PubMed ID: 2828340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.